ENTITY

Stealth BioTherapeutics Inc (1628575D US)

Analysis

Health Care • United States

Stealth BioTherapeutics Inc. operates as a clinical-stage biopharmaceutical company. The Company discovers and develops therapies to treat mitochondrial dysfunction associated with genetic mitochondrial and common diseases of aging. Stealth BioTherapeutics serves customers in the State of Massachusetts.

Refresh

Focused

No publications yet

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00